Kang Xiao

Being Accurate Is Not Enough: New Metrics for Disk Failure Prediction

Gang Wang, Jing Li, Zhongwei Li, 2016, 2016 IEEE 35th Symposium on Reliable Distributed Systems (SRDS).

Claudin1 decrease induced by 1,25-dihydroxy-vitamin D3 potentiates gefitinib resistance therapy through inhibiting AKT activation-mediated cancer stem-like properties in NSCLC cells

Kang Xiao, Xuansheng Ding, Shuo Liu, 2022, Cell death discovery.

PPARα agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARα/AMPK/AKT/FoxO1 pathway

Kang Xiao, Xuan-Sheng Ding, C. Qiao, 2021, Acta Pharmacologica Sinica.

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway

Kang Xiao, Xuansheng Ding, Zhirong Jia, 2023, Pharmaceutical biology.